Panacea Biotec Ltd.
-
NSE: PANACEABIO
-
BSE: 531349
-
Q
-
V
-
T
Quality Score
Medium Financial StrengthValuation Score
Expensive ValuationTechnical Score
Technically BearishTTM PE Ratio
-21.90
Negative PE TTM
Price to Book Ratio
0.90
Low in industry
Operating Revenues Qtr Cr
128.90 Cr
Below industry Median
Net Profit Qtr Cr
-12.70 Cr
Negative Net Profit Qtr Cr
RSI
53.20
RSI is mid-range
MFI
49.10
MFI is mid-range
MACD
0.00
MACD below Signal and Center
MACD Signal Line
0.00
MACD below Signal and Center
30Day SMA Rs
119.90 Rs
price crossed below SMA30 today
50Day SMA Rs
118.10 Rs
price crossed below SMA50 today
100Day SMA Rs
122.10 Rs
Price below SMA-100
200Day SMA Rs
130.80 Rs
Price below SMA-200
Promoter holding %
73.59
No change in Promoter holding
FII holding current Qtr %
0.18
FII holding at 0.18%
MF holding current Qtr %
0.00
MF holding at 0.00%
Institutions holding %
0.61
No change in Institutions holding
Broker Covering stock
0.00
0 Broker Covering stock
Broker 1Year total
0.00
0 Broker 1Year total
Broker 6M Reco downgrade
0.00
0 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
0.00
0 Broker 6M Target downgrade
Broker 6M Target upgrade
0.00
0 Broker 6M Target upgrade
Momentum score
33.33
Technically Bearish
Valuation score
20.83
Expensive Valuation
Quality score
44.64
Medium Financial Strength
-
- 2023-05-31T07:34:50+00:00
PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated May 30, 2023 for approving the Standalone and Consolidated Audited Financial Results of the Company for Quarter and Financial Year ended March 31, 2023 and pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the Extract of Statement of aforesaid Audited Financial Results published in the following newspapers on May 31, 2023:- Business Standard (English); Desh Sewak (Punjabi)
Read More -
- 2023-05-30T12:04:31+00:00
PANACEA BIOTEC LTD. - 531349 - Confirmation Regarding Dispatch Of Reminder Letters To Holders Of Physical Securities For Furnishing Of PAN, KYC Details And Nomination
In compliance to the SEBI Circular, please note that Company has sent reminder letters through registered post, to the shareholders of physical securities for furnishing PAN, KYC details and nomination along with request to dematerialize the shares with Depository Participant.
Read More -
- 2023-05-30T11:16:10+00:00
PANACEA BIOTEC LTD. - 531349 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Secretarial Compliance Report duly issued by R&D Company Secretaries, Practising Company Secretaries for the financial year ended March 31, 2023.
Read More -
- 2023-05-30T09:23:02+00:00
PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023
The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.
Read More -
- 2023-05-30T09:19:11+00:00
PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for Outcome Of Board Meeting
The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023. The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.
Read More -
- 2023-05-15T10:59:32+00:00
PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for For Approving Standalone And Consolidated Audited Financial Results For Financial Year Ended March 31, 2023
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year ended March 31, 2023. Further, with reference to our earlier announcement dated March 30, 2023 intimating the Closure of Trading Window pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window of the Company shall remain closed for all Designated Persons of the Company till June 01, 2023 and the same will re-open from June 02, 2023.
Read More -
- 2023-05-05T09:46:27+00:00
PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During April, 2023 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of April, 2023 along with a copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd., regarding shares dematerialized as on April 30, 2023 .
Read More -
- 2023-04-29T11:49:06+00:00
PANACEA BIOTEC LTD. - 531349 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyPANACEA BIOTEC LTD. 2CIN NO.L33117PB1984PLC022350 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 15.24 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Vinod Goel Designation: Group CFO and Head Legal and Company Secretary EmailId: vinodgoel@panaceabiotec.com Name of the Chief Financial Officer: Devender Gupta Designation: Chief Financial Officer and Head Information Technology EmailId: devendergupta@panaceabiotec.com Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Read More -
- 2023-04-11T08:33:10+00:00
PANACEA BIOTEC LTD. - 531349 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2023
Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s. R & D, Company Secretaries, for the financial year ended March 31, 2023, confirming that all the share certificates have been issued by the Company within the stipulated time from the date of lodgement for transfer, sub-division, consolidation, renewal, exchange or endorsement of calls/allotment monies, as the case may be.
Read More -
- 2023-04-07T07:30:32+00:00
PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During March, 2023
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith the data of shares dematerialized during the month of March, 2023
Read More -
- 2023-04-07T07:26:59+00:00
PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate dated April 03, 2023, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2023.
Read More -
- 2023-04-07T07:24:04+00:00
PANACEA BIOTEC LTD. - 531349 - Compliance Certificate For The Financial Year Ended March 31, 2023
Pursuant to the provisions of Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Services Pvt. Ltd., Share Transfer Agent and Company Secretary of Panacea Biotec Ltd. for the financial year ended on March 31, 2023 in compliance of Regulation 7(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Read More -
- 2023-04-05T11:55:13+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
Read More -
- 2023-04-05T06:27:31+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Rajesh Jain
Read More -
- 2023-03-31T07:33:52+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
Read More -
- 2023-03-31T07:33:52+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
Read More -
- 2023-03-31T06:46:41+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirmala Jain
Read More -
- 2023-03-31T06:44:28+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Jain
Read More -
- 2023-03-31T06:36:44+00:00
PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Rajesh Jain
Read More -
- 2023-03-30T04:44:33+00:00
PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company from April 01, 2023 till completion of 48 hours from the announcement to the Stock Exchanges regarding Audited financial results of the Company for the quarter and financial year ended March 31, 2023. The date of meeting of the Board of Directors to approve the Audited financial results of the Company for the quarter and financial year ended March 31, 2023, shall be informed in due course
Read More
| Ex-date | Dividend Amount | Dividend Type | Record Date |
|---|
Bonus History
Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.
Check out stocks with top dividendAdani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.
| Ex-date | Old FV | New FV | Record Date |
|---|---|---|---|
| Sept. 23, 2010 | 10 | FINAL | Sept. 24, 2010 |